Return of epidemic dengue in the United States: Implications for the public health practitioner

Public Health Reports

Volumn 127, Issue 3, 2012, Pages 259-266

  Bouri, Nidhi ^a   Sell, Tara Kirk ^a   Franco, Crystal ^a   Adalja, Amesh A ^a   Henderson, D A ^a   Hynes, Noreen A ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AEDES AEGYPTI; AEDES ALBOPICTUS; ARTICLE; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; DISEASE CARRIER; DISEASE SEVERITY; DISEASE SURVEILLANCE; EPIDEMIC; HEALTH PRACTITIONER; HUMAN; INFECTION CONTROL; INSECT BITE; PRIORITY JOURNAL; PUBLIC HEALTH; SHOCK; UNITED STATES; VECTOR CONTROL; VIREMIA; VIRUS TRANSMISSION;

EID: 84859448390     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491212700305     Document Type: Article

References (42)

1. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2008;2:e300.
2. Guzman A, Istúriz RE. Update on the global spread of dengue. Int J Antimicrob Agents 2010;36 Suppl 1:S40-S42.
3. Dengue hemorrhagic fever-U.S. Mexico border, 2005 [published erratum appears in MMWR Morb Mortal Wkly Rep 2007;56(32):822]. MMWR Morb Mortal Wkly Rep 2007;56(31):785-789.
4. Effler PV, Pang L, Kitsutani P, Vorndam V, Nakata M, Ayers T, et al. Dengue fever, Hawaii, 2001-2002. Emerg Infect Dis 2005;11:742-749.
5. Locally acquired dengue-Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep 2010;59(19):577-581.
6. Phillips ML. Dengue reborn: widespread resurgence of a resilient vector. Environ Health Perspect 2008;116:A382-A388.
7. World Health Organization. Dengue and dengue haemorrhagic fever: fact sheet 117. March 2009 [cited 2011 Sep 1]. Available from: URL: http://www.who.int/mediacentre/factsheets/fs117/en
8. World Health Organization. Dengue guidelines for diagnosis, treatment, prevention and control. 2nd ed. Geneva: WHO; 2009. Also available from: URL: http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf [cited 2011 Feb 2].
9. Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Yoon I-K, et al. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 2010;4:e617.
10. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181:2-9.
11. Rico-Hesse R, Harrison LM, Salas RA, Rovar D, Nisalak A, Ramos C, et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 1997;230:244-251.
12. Halstead SB, Nimmannitya S, Cohen SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 1970;42:311-328.
13. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998;11:480-496.
14. Moore C. Reported distribution of exotic vectors in the U.S., 2009. Fort Collins (CO): Colorado State University; 2010.
15. Moore CG, Mitchell CJ. Aedes albopictus in the United States: tenyear presence and public health implications. Emerg Infect Dis 1997;3:329-334.
16. Centers for Disease Control and Prevention (US). Map: distribution of Aedes albopictus in the United States, by county, 2000 [cited 2010 Dec 19]. Available from: URL: http://www.cdc.gov/ncidod/dvbid/arbor/albopic_97_sm.htm
17. Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg 1952;1:30-50.
18. Schneider J, Droll D. A timeline for dengue in the Americas to December 31, 2000 and noted first occurrences. Washington: Pan American Health Organization, Division of Disease Prevention and Control; June 2001. Also available from: URL: http://www.paho.org/English/AD/DPC/CD/dengue_finaltime.doc [cited 2011 Apr 13].
19. Gubler DJ. Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem. In: Gubler DJ, Kuno G, editors. Dengue and dengue hemorrhagic fever. London: CAB International; 1997. p. 1-22.
20. Schliessman DJ, Calheiros LB. A review of the status of yellow fever and Aedes aegypti eradication programs in the Americas. Mosquito News 1974;34:1-9.
21. Gubler DJ. Dengue and dengue hemorrhagic fever in the Americas. P R Health Sci J 1987;6:107-111.
22. Gubler DJ. Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up. Charles Franklin Craig Lecture. Am J Trop Med Hyg 1989;40:571-578.
23. Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel. Med Clin North Am 2008;92:1377-1390.
24. Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med 2005;353:924-932.
25. Wilson ME. The traveler and emerging infections: sentinel, courier, transmitter. J Appl Microbiol 2003;94 Suppl:1S-11S.
26. Hawaii State Department of Health. DOH investigates cases of dengue fever on Oahu and asks public & medical community to be vigilant; 2011 Mar 24 [news release] [cited 2011 Apr 28]. Available from: URL: http://hawaii.gov/health/about/dengue/DOH%20Investigates%20Cases%20of%20Dengue.pdf
27. Rawlings JA, Hendricks KA, Burgess CR, Campman RM, Clark GG, Tabony LJ, et al. Dengue surveillance in Texas, 1995. Am J Trop Med Hyg 1998;59:95-99.
28. Rico-Hesse R. Dengue virus evolution and virulence models. Clin Infect Dis 2007;44:1462-1466.
29. Reiter P, Lathrop S, Bunning M, Biggerstaff B, Singer D, Tiwari T, et al. Texas lifestyle limits transmission of dengue virus. Emerg Infect Dis 2003;9:86-89.
30. Ramos MM, Mohammed H, Zielinski-Gutierrez E, Hayden MH, Lopez JL, Fournier M, et al. Epidemic dengue and dengue hemorrhagic fever at the Texas-Mexico border: results of a household-based seroepidemiologic survey, December 2005. Am J Trop Med Hyg 2008;78:364-369.
31. Florida Department of Health, Division of Environmental Public Health. Florida arbovirus surveillance-week 4: January 23-January 29, 2011 [cited 2011 Feb 13]. Available from: URL: http://www.doh.state.fl.us/environment/medicine/arboviral/pdfs/2011/2011Week4ArbovirusReport_1-29-2011.pdf
32. Florida Department of Health, Division of Environmental Public Health. Florida arbovirus surveillance-week 9: February 27-March 5, 2011 [cited 2011 May 4]. Available from: URL: http://www.doh.state.fl.us/environment/medicine/arboviral/pdfs/2011/2011Week9ArbovirusReport_3-05-2011.pdf
33. Centers for Disease Control and Prevention (US). Event code list: nationally notifiable diseases and other conditions of public health importance. January 2010 [cited 2011 Apr 14]. Available from: URL: http://www.cdc.gov/osels/ph_surveillance/nndss/phs/files/NNDSS_event_code_list_January_2010.pdf
34. th ed. Philadelphia: Churchill Livingstone; 2010. p. 153.
35. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988;38:411-419.
36. World Health Organization Regional Office for South East Asia. Prevention and control of dengue fever and dengue haemorrhagic fever: comprehensive guidelines [cited 2011 Sep 1]. Available from: URL: http://www.searo.who.int/LinkFiles/Regional_Guidelines_on_Dengue_DHF_prevention_&_control_searo-29.pdf
37. Centers for Disease Control and Prevention (US). Criteria for the processing of dengue samples at the CDC Dengue Branch, San Juan, Puerto Rico [cited 2010 Dec 20]. Available from: URL: http://www.cdc.gov/Dengue/resources/TestpolEng_2.pdf
38. Sathish N, Vijayakumar TS, Abraham P, Sridharan G. Dengue fever: its laboratory diagnosis, with special emphasis on IgM detection. Dengue Bulletin 2003;27:116-125.
39. Beatty ME, Stone A, Fitzsimons DW, Hanna JN, Lam SK, Vong S, et al. Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis 2010;4:e890.
40. Vazquez-Prokopec GM, Chaves LF, Ritchie SA, Davis J, Kitron U. Unforeseen costs of cutting mosquito surveillance budgets. PLoS Negl Trop Dis 2010;4:e858.
41. American Mosquito Control Association. Public-health pesticide applicator training manual for the USA and its territories [cited 2010 Dec 19]. Available from: URL: http://entnemdept.ufl.edu/fasulo/vector/manual.htm
42. Voelker R. Race is on for effective dengue vaccine. JAMA 2010;304:1430-1431.